Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-017-3659-7
Abstract: ObjectivesStage IIIA non-small cell lung cancer (NSCLC) is heterogeneous in tumor burden, and its treatment is variable. Whole-body metabolic tumor volume (MTVWB) has been shown to be an independent prognostic index for overall survival (OS).… read more here.
Keywords: stage iiia; risk; iiia patients; mtvwb ... See more keywords